Thyroid Cancer

 

Pazopanib in Combination w/ Radioactive 131I (7529)
A Phase I Clinical Trial of Pazopanib in Combination with Escalating Doses of Radioactive 131I in Patients with Well-Differentiated Thyroid Carcinoma Refractory to Radioiodine, Despite Having Some Uptake

Investigator: Laura Chow;   Conditions: Thyroid Cancer;    Status: Recruiting;   Study ID: NCT01413113